The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

EXPERT’Biome, CDMO By Lallemand, Acquires Bacthera Equipment
Finance

EXPERT’Biome, CDMO By Lallemand, Acquires Bacthera Equipment

SEP 9, 2025
MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
Editor's Choice

MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline

SEP 4, 2025
New study explores effects of fungicide use on corn health and microbiome
Phytobiome & Environment

New study explores effects of fungicide use on corn health and microbiome

AUG 25, 2025
Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
Editor's Choice

Targeting the ileo-colonic region: Innovative solutions for sensitive APIs

AUG 21, 2025
SNIPR BIOME Raises EUR 35 Million Series B Financing
Finance

SNIPR BIOME Raises EUR 35 Million Series B Financing

AUG 7, 2025
Experts publish first global framework for quantifying postbiotics
Biotics and Supplements

Experts publish first global framework for quantifying postbiotics

AUG 7, 2025
$2.6M NIH grant to fund new microbiome sciences training program at Penn State
Pharma & Human Health

$2.6M NIH grant to fund new microbiome sciences training program at Penn State

JUL 24, 2025
BioGaia launches subsidiary company dedicated to advancing microbiome research and innovation
Finance

BioGaia launches subsidiary company dedicated to advancing microbiome research and innovation

JUL 21, 2025
New UK research network to unlock gut, immune and brain health links
Gut-Brain Axis

New UK research network to unlock gut, immune and brain health links

JUL 9, 2025
Towards a diagnostic test: the gut microbiome as a clinical target for screening for colorectal cancer
Gastrointestinal

Towards a diagnostic test: the gut microbiome as a clinical target for screening for colorectal cancer

JUL 2, 2025
Danone further invests in next-generation biotics with acquisition of The Akkermansia Company
Finance

Danone further invests in next-generation biotics with acquisition of The Akkermansia Company

JUN 26, 2025